AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34526434 — intervention group
Group type: EXPERIMENTAL
Intervention: ARC‐HBR criteria group 4 (2 majors with ≥ 0 minors, N=861)
Number of subjects: 12093
Study 34526434 — intervention group
Group type: EXPERIMENTAL
Intervention: ARC‐HBR criteria group 5 (≥ 3 majors with ≥ 0 minor, N=236)
Number of subjects: 12093
Study 34526434 — intervention group
Group type: COMPARATOR
Intervention: Non-ARC‐HBR criteria group 0 (N=6,792)
Number of subjects: 12093
Study 34016887 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliopancreatic drainage
Number of subjects: 20
Study 34016887 — intervention group
Group type: COMPARATOR
Intervention: Biliary drainage
Number of subjects: 20
Study 32173035 — intervention group
Group type: EXPERIMENTAL
Intervention: Congenitally blind (CB) children
Number of subjects: 45
Study 32173035 — intervention group
Group type: COMPARATOR
Intervention: Eyes closed (EC) group
Number of subjects: 45
Study 32173035 — intervention group
Group type: COMPARATOR
Intervention: Eyes open (EO) group
Number of subjects: 45
Study 35871814 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg per day
Number of subjects: 727
Study 35871814 — intervention group
Group type: COMPARATOR
Intervention: Dupilumab 300 mg every 2 weeks
Number of subjects: 727
Study 33617144 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpine treeline ecotones (ATEs)
Number of subjects: 10
Study 33617144 — intervention group
Group type: COMPARATOR
Intervention: Other forest ecotones (OFEs)
Number of subjects: 10
Study 33617144 — intervention group
Group type: COMPARATOR
Intervention: Forests below ATEs
Number of subjects: 10
Study 32150215 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month structured physical activity with or without a protein and vitamin D nutritional supplement
Number of subjects: 99
Study 35075385 — intervention group
Group type: EXPERIMENTAL
Intervention: Huaiqihuang granules combined with comprehensive nursing
Number of subjects: 104
Study 35075385 — intervention group
Group type: COMPARATOR
Intervention: Glucocorticoid (Control)
Number of subjects: 104
Study 34246888 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitoleic acid (genetically predicted levels)
Number of subjects: 14361
Study 34246888 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleic acid (genetically predicted levels)
Number of subjects: 14361
Study 34246888 — intervention group
Group type: COMPARATOR
Intervention: Genetic predisposition to MUFAs
Number of subjects: 14361
Study 35619221 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin treatment (10 mg)
Number of subjects: 17
Study 35619221 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 17
Study 34424558 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment shampoo and leave‐on treatment containing functional antioxidants and barrier‐enhancing agents
Number of subjects: 0
Study 34424558 — intervention group
Group type: COMPARATOR
Intervention: Placebo chassis shampoo control
Number of subjects: 0
Study 32334176 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically indicated replacement group (removal only at end of therapy or in presence of complications)
Number of subjects: 1319
Study 32334176 — intervention group
Group type: COMPARATOR
Intervention: Routine replacement group (catheters replaced every 96 hours unless clinical reasons required earlier replacement)
Number of subjects: 1319
Study 34265165 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee pulp drink (CPD)
Number of subjects: 80
Study 34265165 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee pulp serum (CPS)
Number of subjects: 80
Study 34265165 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 80
Study 34265165 — intervention group
Group type: COMPARATOR
Intervention: Placebo serum
Number of subjects: 80
Study 33421538 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation with multimodal exercise program
Number of subjects: 46
Study 33421538 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 46
Study 33421538 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EG and CG)
Number of subjects: 46
Study 33421538 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (EG)
Number of subjects: 46
Study 35035241 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian ginseng and American ginseng
Number of subjects: 91
Study 35035241 — intervention group
Group type: EXPERIMENTAL
Intervention: Publication date and sample size
Number of subjects: 91
Study 35035241 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigorous RCTs designed for ginseng
Number of subjects: 91
Study 32590482 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromfenac ophthalmic solution 0.09% prescribed 3 times a day for 1 month
Number of subjects: 450
Study 32590482 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone acetate 1% eye suspension prescribed 4 times a day for 1 month
Number of subjects: 450
Study 32590482 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone acetate 1% prescribed 4 times a day for 2 weeks and bromfenac 2 times a day for 1 month
Number of subjects: 450
Study 35418437 — intervention group
Group type: EXPERIMENTAL
Intervention: MLC901 (NeuroAiD II)
Number of subjects: 0
Study 35418437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36281150 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation (30 minutes)
Number of subjects: 39
Study 36281150 — intervention group
Group type: EXPERIMENTAL
Intervention: MLD plus Rehabilitation (30 minutes MLD + 30 minutes rehabilitation)
Number of subjects: 39
Study 36281150 — intervention group
Group type: EXPERIMENTAL
Intervention: MLD plus Rehabilitation
Number of subjects: 39
Study 36281150 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation
Number of subjects: 39
Study 33557898 — intervention group
Group type: EXPERIMENTAL
Intervention: Shi-style cervical manipulation therapy
Number of subjects: 240
Study 33557898 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (traditional analgesic drug)
Number of subjects: 240
Study 34938867 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 199
Study 34938867 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 199
Study 34612617 — intervention group
Group type: EXPERIMENTAL
Intervention: 8.4% sodium bicarbonate
Number of subjects: 90
Study 34612617 — intervention group
Group type: COMPARATOR
Intervention: 20% mannitol
Number of subjects: 90
Study 34612617 — intervention group
Group type: COMPARATOR
Intervention: 3% hypertonic saline
Number of subjects: 90
Study 32464957 — intervention group
Group type: EXPERIMENTAL
Intervention: CLAD patients (M30, MUC1, MUC16)
Number of subjects: 45
Study 32464957 — intervention group
Group type: EXPERIMENTAL
Intervention: RAS/mixed phenotype patients (M30)
Number of subjects: 45
Study 32464957 — intervention group
Group type: COMPARATOR
Intervention: CLAD-free controls
Number of subjects: 45
Study 32567869 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgender affirmative psychotherapy (TA)
Number of subjects: 20
Study 32567869 — intervention group
Group type: EXPERIMENTAL
Intervention: Building Awareness of Minority Stressors + Transgender Affirmative psychotherapy
Number of subjects: 20
Study 32246685 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 15
Study 32246685 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (SCTG)
Number of subjects: 15
Study 33978329 — intervention group
Group type: EXPERIMENTAL
Intervention: Modifiable risk factors
Number of subjects: 380
Study 33978329 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmodifiable risk factors
Number of subjects: 380
Study 33978329 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modifiable and nonmodifiable risk factors
Number of subjects: 380
Study 33978329 — intervention group
Group type: COMPARATOR
Intervention: Overall risk factors presence
Number of subjects: 380
Study 33331082 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg IV every 4 weeks; 6 doses)
Number of subjects: 30
Study 33331082 — intervention group
Group type: COMPARATOR
Intervention: No treatment (controls)
Number of subjects: 30
Study 36443789 — intervention group
Group type: EXPERIMENTAL
Intervention: Social risk screening and assessment of desire for assistance using the Accountable Health Communities instrument.
Number of subjects: 228
Study 36443789 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire for assistance assessment.
Number of subjects: 228
Study 35833970 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) underwent a 1-year lifestyle intervention with 4 months of active weight loss (WL) followed by 8 months of WL maintenance.
Number of subjects: 94
Study 35833970 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) after weight loss (WL)
Number of subjects: 94
Study 35833970 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) with higher energy conservation
Number of subjects: 94
Study 35833970 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 94
Study 37749703 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified milk (1500 IU vitamin D3)
Number of subjects: 289
Study 37749703 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified yogurt (1500 IU vitamin D3)
Number of subjects: 289
Study 37749703 — intervention group
Group type: COMPARATOR
Intervention: Plain milk (Control)
Number of subjects: 289
Study 37749703 — intervention group
Group type: COMPARATOR
Intervention: Plain yogurt (Control)
Number of subjects: 289
Study 37749703 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified products (milk and yogurt)
Number of subjects: 289
Study 33370867 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangbingdu granules (KBD), 18g each time, 3 times a day for 5 days
Number of subjects: 393
Study 33370867 — intervention group
Group type: COMPARATOR
Intervention: Oseltamivir phosphate capsule, 75 mg each time, twice a day for 5 days
Number of subjects: 393
Study 32382987 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-world evidence (RWE) studies
Number of subjects: 0
Study 32382987 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequencing of novel agents based on RWE data
Number of subjects: 0
Study 35077456 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiroxostat
Number of subjects: 141
Study 35077456 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 141
Study 33412120 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib (150 mg orally twice daily)
Number of subjects: 576
Study 33412120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study 33412120 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 576
Study 33412120 — intervention group
Group type: COMPARATOR
Intervention: Nintedanib and Placebo
Number of subjects: 576
Study 35678081 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical time intervention‐task shifting (CTI‐TS) for 9 months
Number of subjects: 110
Study 35678081 — intervention group
Group type: COMPARATOR
Intervention: Usual care for 9 months
Number of subjects: 110
Study 34091874 — intervention group
Group type: EXPERIMENTAL
Intervention: Citicoline and vitamin B12 eye drops (OMK2®, Omikron Italia srl, Italy, one drop thrice daily) for 36 months
Number of subjects: 20
Study 34091874 — intervention group
Group type: COMPARATOR
Intervention: Placebo (eye drops containing hypromellose 0.3%, one drop thrice daily) for 36 months
Number of subjects: 20
Study 32787893 — intervention group
Group type: EXPERIMENTAL
Intervention: Thursdays at the Museum (art-based workshops)
Number of subjects: 150
Study 32787893 — intervention group
Group type: COMPARATOR
Intervention: Control group (no participation in art-based activities)
Number of subjects: 150
Study 34142455 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D anatomy application
Number of subjects: 76
Study 34142455 — intervention group
Group type: COMPARATOR
Intervention: Anatomy atlases
Number of subjects: 76
Study 34960030 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg PXN + 150 mg PLA
Number of subjects: 12
Study 34960030 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg PXN + 100 mg PLA
Number of subjects: 12
Study 34960030 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg PXN
Number of subjects: 12
Study 34960030 — intervention group
Group type: COMPARATOR
Intervention: 200 mg PLA
Number of subjects: 12
Study 35115348 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sampling HPV test
Number of subjects: 20000
Study 35115348 — intervention group
Group type: COMPARATOR
Intervention: Routine cervical cancer screening (cytology test)
Number of subjects: 20000
Study 33910657 — intervention group
Group type: EXPERIMENTAL
Intervention: Resident involvement
Number of subjects: 11733
Study 33910657 — intervention group
Group type: COMPARATOR
Intervention: Control (no resident involvement)
Number of subjects: 11733
Study 36309929 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Transdiagnostic Protocol (UP) for 10 sessions
Number of subjects: 45
Study 36309929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction Protocol (MBSR) for 8 sessions
Number of subjects: 45
Study 36309929 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 45
Study 34037889 — intervention group
Group type: EXPERIMENTAL
Intervention: ECP (300 mmHg)
Number of subjects: 43
Study 34037889 — intervention group
Group type: COMPARATOR
Intervention: Sham/control (75 mmHg)
Number of subjects: 43
Study 32896158 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive CMC
Number of subjects: 62
Study 32896158 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative CMC
Number of subjects: 62
Study 32896158 — intervention group
Group type: COMPARATOR
Intervention: Blog
Number of subjects: 62
Study 32098895 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyclonal Tregs
Number of subjects: 3
Study 32098895 — intervention group
Group type: EXPERIMENTAL
Intervention: Proinsulin-specific Tregs
Number of subjects: 3
Study 32098895 — intervention group
Group type: COMPARATOR
Intervention: Long-duration T1DM (LDT1DM)
Number of subjects: 3
Study 35459194 — intervention group
Group type: EXPERIMENTAL
Intervention: CBEP-HCP (community-based exercise program with healthcare-community partnerships)
Number of subjects: 33
Study 35459194 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 33
Study 32665211 — intervention group
Group type: EXPERIMENTAL
Intervention: Hiraoka's TUDP
Number of subjects: 104
Study 32665211 — intervention group
Group type: COMPARATOR
Intervention: TURP
Number of subjects: 104
Study 33306939 — intervention group
Group type: EXPERIMENTAL
Intervention: LPG stove intervention with continuous fuel delivery for 1 year, education, and behavioral messaging
Number of subjects: 180
Study 33306939 — intervention group
Group type: COMPARATOR
Intervention: Control group continued usual cooking practices
Number of subjects: 180
Study 36104785 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised unfractionated heparin 6 hourly to day 10 while receiving advanced respiratory support
Number of subjects: 40
Study 36104785 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 40
Study 34101937 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief mindfulness instructions
Number of subjects: 62
Study 34101937 — intervention group
Group type: COMPARATOR
Intervention: Suppression instructions
Number of subjects: 62
Study 34101937 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconditioned (novel-cued) stimuli
Number of subjects: 62
Study 32854153 — intervention group
Group type: EXPERIMENTAL
Intervention: Work-HIIT (n = 24)
Number of subjects: 47
Study 36206973 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic configuration assessment
Number of subjects: 90
Study 36206973 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis between thoracic area and spirometry variables
Number of subjects: 90
Study 33403886 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Pressure <140/90 mmHg
Number of subjects: 5250
Study 33403886 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Pressure <130/80 mmHg
Number of subjects: 5250
Study 32727416 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral surgical resection with neck dissection followed by risk-adapted adjuvant therapy
Number of subjects: 280
Study 32727416 — intervention group
Group type: COMPARATOR
Intervention: Standard chemoradiation
Number of subjects: 280
Study 36497969 — intervention group
Group type: EXPERIMENTAL
Intervention: Training intervention in energy management strategies
Number of subjects: 86
Study 36497969 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 86
Study 33811385 — intervention group
Group type: EXPERIMENTAL
Intervention: Linked color imaging (LCI)
Number of subjects: 90
Study 33811385 — intervention group
Group type: COMPARATOR
Intervention: White light imaging (WLI)
Number of subjects: 90
Study 35675742 — intervention group
Group type: EXPERIMENTAL
Intervention: Bee-humming respiratory training (BHRT), 30 minutes daily for 4 weeks
Number of subjects: 46
Study 35675742 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study 35675742 — intervention group
Group type: EXPERIMENTAL
Intervention: Bee-humming respiratory training (BHRT)
Number of subjects: 46
Study 33650100 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib (20 mg/m2 on day 1, escalating to 56 mg/m2 maximum) with dexamethasone (10 mg as premedication) during maintenance
Number of subjects: 8
Study 33650100 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib with cyclophosphamide and dexamethasone (KCd) during induction
Number of subjects: 8
Study 33650100 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib during KCd consolidation
Number of subjects: 8
Study 33650100 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance single-agent carfilzomib
Number of subjects: 8
Study 33650100 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall TMA incidence
Number of subjects: 8
Study 33471664 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary diabetes program
Number of subjects: 192
Study 33471664 — intervention group
Group type: COMPARATOR
Intervention: Standard primary care setting (control group)
Number of subjects: 192
Study 34964860 — intervention group
Group type: EXPERIMENTAL
Intervention: MARPE
Number of subjects: 60
Study 34964860 — intervention group
Group type: EXPERIMENTAL
Intervention: RPE
Number of subjects: 60
Study 34964860 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 32960350 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone otoscope
Number of subjects: 52
Study 32960350 — intervention group
Group type: COMPARATOR
Intervention: Traditional otoscope
Number of subjects: 52
Study 35685082 — intervention group
Group type: EXPERIMENTAL
Intervention: GA + ESPB
Number of subjects: 60
Study 35685082 — intervention group
Group type: COMPARATOR
Intervention: GA
Number of subjects: 60
Study 34369682 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with ultrasound guided caudal epidural injection
Number of subjects: 60
Study 34369682 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound guided caudal epidural injection
Number of subjects: 60
Study 36414626 — intervention group
Group type: EXPERIMENTAL
Intervention: KarXT (xanomeline-trospium)
Number of subjects: 125
Study 36414626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 33955318 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 105
Study 33955318 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 105
Study 36087136 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional counselling intervention based on unprocessed and minimally processed foods and physical activities
Number of subjects: 350
Study 36087136 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 350
Study 33401605 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT intervention and health education
Number of subjects: 70
Study 33401605 — intervention group
Group type: COMPARATOR
Intervention: Health education alone
Number of subjects: 70
Study 32805626 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically-predicted TNF levels
Number of subjects: 30912
Study 34384513 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Schools intervention (providing free refillable water bottles and educational material)
Number of subjects: 569
Study 34384513 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 569
Study 33566077 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorides for intensive prophylaxis for the first month
Number of subjects: 36
Study 33566077 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine for intensive prophylaxis for the first month
Number of subjects: 36
Study 33566077 — intervention group
Group type: COMPARATOR
Intervention: Regular oral hygiene (Control group)
Number of subjects: 36
Study 35932953 — intervention group
Group type: EXPERIMENTAL
Intervention: Furmonertinib 80mg Qd
Number of subjects: 358
Study 35932953 — intervention group
Group type: COMPARATOR
Intervention: Gefitinib 250mg Qd
Number of subjects: 358
Study 33434565 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully automated AI-driven tooth segmentation (F-AI)
Number of subjects: 314
Study 33434565 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined AI-driven tooth segmentation (R-AI)
Number of subjects: 314
Study 33434565 — intervention group
Group type: COMPARATOR
Intervention: Semiautomated tooth segmentation (SA)
Number of subjects: 314
Study 35634694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg plus alcohol (males, 0.7 g/kg; females, 0.6 g/kg)
Number of subjects: 32
Study 35634694 — intervention group
Group type: COMPARATOR
Intervention: Alcohol alone
Number of subjects: 32
Study 35634694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg alone
Number of subjects: 32
Study 35634694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg plus alcohol
Number of subjects: 32
Study 35634694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg alone or with alcohol
Number of subjects: 32
Study 35754259 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pain competence and depression prevention training (n=271)
Number of subjects: 526